Nearly one in three people with a recent acute illness in four Tanzanian regions went to an accredited drug dispensing outlet (ADDO) for care, according to a household survey published in 2016. Of 614 household members who had been ill in the previous two weeks, 30.9% used an ADDO or drug store, compared with 18.3% at a public health centre or dispensary and 12.0% at a public hospital.
Those figures describe ADDOs in Morogoro, Singida, Mbeya and Tanga. They do not describe Part I community pharmacies, and no source consulted for this article gives a current national picture of where patients go first. What the evidence does show is that the outlets patients use sit under rules set by several bodies, and that daily practice inside those rules is decided by owners and dispensers.
Five groups shape private community pharmacy: the Pharmacy Council of Tanzania, the Tanzania Medicines and Medical Devices Authority (TMDA), the Ministry of Health, the owners and pharmacists who run outlets, and patients. Their influence differs, and so does the evidence for each. This article covers Mainland Tanzania. Zanzibar has separate arrangements that it does not examine.
The Pharmacy Council decides who practises and where
Under the Pharmacy Act, 2011 (Act No. 1 of 2011), the Pharmacy Council is the sole authority for registering pharmacists, enrolling pharmaceutical technicians and listing pharmaceutical assistants (section 4). The Act also directs it to uphold acceptable standards of pharmacy practice in the public and private sectors (section 4(c)) and lets it remove names from the register, roll or list (section 5(c)).
Premises are the Council’s second lever. Nobody may sell, dispense or supply medicinal products except in premises registered under the Act (section 34(1)), and each set of premises needs its own permit (section 36(4)). An owner who changes the ownership of a business must notify the Council, and under section 35 the registration ceases 30 days after the change. Anyone buying an existing pharmacy should therefore treat registration as something the new owner must secure, not something that comes with the shop.
The Council also approves training institutions and their curricula (section 5(h)). That is a slow form of influence, because it shapes the cadres who later staff outlets. The text of the Act consulted here does not define ADDOs or ADDO dispensers, so their status rests on other instruments that this article has not reviewed.
TMDA decides what can be sold
TMDA is established by section 4(1) of the Tanzania Medicines and Medical Devices Act (Cap. 219), and it took over from the Tanzania Food and Drugs Authority (TFDA) following amendments made in 2019. Section 5(1) requires it to regulate the quality and safety of drugs, herbal drugs, medical devices and poisons, to approve and register products, and to see that information on adverse events is monitored and acted on.
For a pharmacy, this means TMDA’s registration decisions determine which products are on the market, and its pharmacovigilance function is where a suspected adverse reaction should end up. The Council regulates the person and the premises. TMDA regulates the product.
Health insurance reform leaves a question for pharmacies
The Ministry of Health sets national health policy, and its most concrete recent move on financing is the Universal Health Insurance Act. The Citizen reported on 6 December 2023 that the President had signed the bill, and that the Ministry could now begin drafting regulations to implement it. The report does not say whether or how private pharmacies or ADDOs will be paid under the scheme.
That gap matters commercially. If outlets can be accredited to dispense to insured patients, the scheme could change who walks through the door. If they cannot, it may not. Owners will find the answer in the implementing regulations and in the accreditation rules of the insurers, not in general statements about universal coverage.
Scope rules matter too. The 2016 ADDO study noted that ADDOs may sell only a few chronic-disease medicines, which its authors called a gap given the burden of noncommunicable disease. Whether that limit has changed since 2016 is unverified.
Owners and pharmacists decide how the rules play out
Regulation sets the boundaries, and practice happens inside them. In a 2022 simulated-client study in Kilimanjaro, Mbeya and Mwanza, trained clients presented with urinary tract infection symptoms and no prescription at 672 outlets: 559 ADDOs and 113 community pharmacies. In 601 of the 672 visits (89.43%), the seller recommended an antibiotic.
The rate was 90.0% in ADDOs and 86.7% in community pharmacies, a difference that was not statistically significant. The problem cannot be assigned to one outlet type. The authors also note that the outlets were mostly urban, that Mwanza dominated the sample, and that the method shows what sellers do but not why. One scenario in three regions cannot stand for the whole sector.
The study measured non-prescribed recommendations, not legality. Which antibiotics may lawfully be sold without a prescription depends on their classification, which this article has not reviewed. Within whatever the rules allow, owners control supervision, staff training and referral arrangements, and those decide whether a request for an antibiotic ends in a sale, a question or a referral.
Patients and communities set the demand
Public knowledge is thin. In a four-region household survey of 1,200 people, also published in 2016, 404 had heard of an antimicrobial. Awareness was 41.8% in areas with many ADDOs and 19.7% where there were none. The authors read this as support for ADDO dispensers as sources of community information, but the survey shows an association and cannot show that ADDOs caused the difference.
For pharmacies, low awareness means counselling carries real weight. A patient who has not heard of antimicrobial resistance (AMR) is unlikely to arrive asking about it.
What owners and pharmacists can act on
- Check section 35 of the Pharmacy Act, and the Council’s current procedure, before buying or selling a pharmacy business.
- Watch for the implementing regulations of the Universal Health Insurance Act and the accreditation rules that follow, because they may decide whether insured patients can use private outlets.
- Audit how staff respond to antibiotic requests without a prescription, and put referral and counselling steps in writing.
